
Monopore S 1000mg/500mg Injection
Marketer
Helplab Healthcare Pvt Ltd
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Monopore S 1000mg/500mg Injection
Synergix-B 1000mg/500mg Injection, a dual-action antibiotic, targets a wide spectrum of bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be strictly under medical guidance. Complete the prescribed dosage; premature cessation can compromise efficacy. Regularly scheduled appointments are crucial. Typical mild side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your physician. Seek immediate emergency care for allergic reactions (e.g., rash, itching, edema, dyspnea). Inform your doctor about all concurrent medications, especially if you're pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is usually unaffected, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment effectiveness.
Uses of Monopore S 1000mg/500mg Injection
Managing bacterial infections
Major Benefits of Monopore S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Monopore S 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Monopore S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Monopore S 1000mg/500mg Injection works:
Monopore S Injection (1000mg/500mg) combines the antibiotic Cefoperazone with the beta-lactamase inhibitor Sulbactam. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thus boosting Cefoperazone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingesting alcohol during Monopore S 1000mg/500mg Injection treatment can trigger adverse effects including facial redness, rapid pulse, queasiness, dehydration, pectoral discomfort, and hypotension (a disulfiram-like response).
PregnancySAFE IF PRESCRIBED
The injectable medication Monopore S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; yet, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Monopore S (1000mg/500mg) poses no known breastfeeding safety risk. Research in humans indicates negligible transfer into breast milk, thereby minimizing potential infant harm.
DrivingCONSULT YOUR DOCTOR
The effect of Monopore S 1000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Monopore S 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Monopore S 1000mg/500mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Monopore S 1000mg/500mg Injection :
Should you forget a scheduled Monopore S 1000mg/500mg Injection, seek advice from your physician.
Facts to Know About Monopore S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
